Cover Image
市場調查報告書

全球左心耳封閉市場:2017∼2021年

Global Left Atrial Appendage Closure Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 346668
出版日期 內容資訊 英文 115 Pages
訂單完成後即時交付
價格
Back to Top
全球左心耳封閉市場:2017∼2021年 Global Left Atrial Appendage Closure Market 2017-2021
出版日期: 2017年01月02日 內容資訊: 英文 115 Pages
簡介

心房纖維顫動是心律不整的最常見的類型之一,引起胸痛和心臟衰竭,中風。全球左心耳封閉市場,預計2017∼2021年以33.54%的年複合成長率擴大。

本報告提供全球左心耳封閉市場相關調查,市場趨勢與課題,各產品,各終端用戶,及各地區趨勢,到2021年為止的市場成長預測,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 波特的五力分析

第6章 開發平台分析

第7章 臨床實驗

第8章 左心耳封閉設備相關法規

第9章 各產品市場區隔

  • 心外膜左心耳封閉設備
  • 心內膜左心耳封閉設備

第10章 各終端用戶市場區隔

  • 醫院
  • 門診外科中心
  • 心臟診所

第11章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第12章 推動市場的要素

第13章 促進要素的影響

第14章 市場課題

第15章 促進要素與課題的影響

第16章 市場趨勢

第17章 供應商環境

  • 競爭模式
  • 主要消息
  • 合併、收購

第18章 主要供應商分析

  • AtriCure
  • Boston Scientific
  • Coherex Medical
  • St. Jude Medical
  • 其他值得注意的供應商

第19章 附錄

第20章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR11341

About Left Atrial Appendage Closure

Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the disease do not function properly. Atrial fibrillation can cause chest pain, heart failure, or stroke. The doctor needs to identify the first detected event of atrial fibrillation in a patient. The occurrence of two or more events of atrial fibrillation results in it being considered recurrent. In paroxysmal atrial fibrillation, the arrhythmia ends spontaneously, whereas in persistent atrial fibrillation the arrhythmia continues for more than a week.

Technavio's analysts forecast the global left atrial appendage closure market to grow at a CAGR of 33.54% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global left atrial appendage closure market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of medical devices required for left atrial appendage closure.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Left Atrial Appendage Closure Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AtriCure
  • Boston Scientific
  • Coherex Medical
  • St. Jude Medical

Other Prominent Vendors

  • Occlutech
  • Lifetech Scientific
  • SentreHEART

Market driver

  • Increasing incidences of atrial fibrillation
  • For a full, detailed list, view our report

Market challenge

  • Increasing product recalls hindering growth prospects
  • For a full, detailed list, view our report

Market trend

  • Emergence of 3D printing technology
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our procurement specialist's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights
  • Atrial fibrillation
  • LAA closure devices

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Pipeline analysis

PART 07: Clinical trials

PART 08: Regulation of LAA closure devices

PART 09: Market segmentation by product type

  • Epicardial LAA closure device
  • Endocardial LAA closure device

PART 10: Market segmentation by end-user

  • Hospitals
  • ASCs
  • Heart clinics

PART 11: Geographical segmentation

  • LAA closure market in Americas
  • LAA closure market in EMEA
  • LAA closure market in APAC

PART 12: Market drivers

  • Increasing incidences of atrial fibrillation
  • Growing product approvals fueling market growth
  • Potential long-term cost-effectiveness associated with use of LAA closure devices
  • Shift from open to MI surgeries

PART 13: Impact of drivers

PART 14: Market challenges

  • Increasing product recalls hindering growth prospects
  • High acceptance of warfarin and dabigatran
  • Stringent regulatory environment affecting product approvals
  • Complications associated with LAA closure procedures

PART 15: Impact of drivers and challenges

PART 16: Market trends

  • Emergence of 3D printing technology
  • Emergence of hybrid approach in LAA closure techniques
  • Growing focus on clinical trials
  • Rising inorganic growth strategies

PART 17: Vendor landscape

  • Competitive scenario
  • Key news
  • M&A

PART 18: Key vendor analysis

  • AtriCure
  • Boston Scientific
  • Coherex Medical2
  • St. Jude Medical6
  • Other prominent vendors2

PART 19: Appendix3

  • List of abbreviations3

PART 20: Explore Technavio4

List of Exhibits

  • Exhibit 01: Snapshot of LAA closure market in 2016
  • Exhibit 02: Factors affecting LAA closure market
  • Exhibit 03: Snapshot of global LAA closure market
  • Exhibit 04: Timeline chart representing the approvals for LAA closure devices
  • Exhibit 05: Factors driving demand for LAA closure devices
  • Exhibit 06: Global LAA closure market 2016-2021 ($ millions)
  • Exhibit 07: Opportunity analysis of global LAA closure market
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Snapshot of regulation of medical devices
  • Exhibit 10: Timeline of key events - WATCHMAN device regulations
  • Exhibit 11: Global LAA closure devices market segmentation by product type
  • Exhibit 12: Global LAA closure market segmentation by product type 2016 and 2021 (%)
  • Exhibit 13: Lifecycle analysis of global LAA closure market by product type
  • Exhibit 14: Global LAA closure market segmentation by product type 2016: Lifecycle analysis
  • Exhibit 15: Epicardial and endocardial LAA closure classification
  • Exhibit 16: Global LAA closure market segmentation by product type analysis
  • Exhibit 17: Highlights of endocardial LAA closure market
  • Exhibit 18: Global epicardial LAA closure market 2016-2021 ($ millions)
  • Exhibit 19: Highlights of endocardial LAA closure market
  • Exhibit 20: Global endocardial LAA closure market 2016-2021 ($ millions)
  • Exhibit 21: Global LAA closure market segmentation by product type 2016-2021 ($ millions)
  • Exhibit 22: Global LAA closure market segmentation by product type 2016-2021 (%)
  • Exhibit 23: Global LAA closure market segmentation by end-user 2016
  • Exhibit 24: Global LAA closure market segmentation by geography 2016 and 2021 (%)
  • Exhibit 25: Global LAA closure market segmentation by geography 2016: Analysis
  • Exhibit 26: Market growth lifecycle analysis of global LAA closure devices by geography
  • Exhibit 27: Market overview: Americas
  • Exhibit 28: LAA closure devices approvals until 2016 in Americas
  • Exhibit 29: LAA closure market in Americas 2016-2021 ($ millions)
  • Exhibit 30: Market overview: EMEA
  • Exhibit 31: LAA closure market in EMEA 2016-2021 ($ millions)
  • Exhibit 32: Product approvals in EMEA until 2016
  • Exhibit 33: Market overview: APAC
  • Exhibit 34: LAA closure market in APAC 2016-2021 ($ millions)
  • Exhibit 35: Global LAA closure market segmentation by geography 2016-2021 ($ millions)
  • Exhibit 36: Global LAA closure market segmentation by geography 2016-2021 (%)
  • Exhibit 37: Incidences of atrial fibrillation
  • Exhibit 38: Key product approvals
  • Exhibit 39: Key takeaways associated with cost-effectiveness of LAA closure devices
  • Exhibit 40: Key factors fueling the adoption rates of LAA closure devices
  • Exhibit 41: Impact of drivers
  • Exhibit 42: Major product recalls
  • Exhibit 43: Key factors fueling the adoption of warfarin and dabigatran
  • Exhibit 44: Key factors hindering the product approvals
  • Exhibit 45: Complications involved in LAA closure devices
  • Exhibit 46: Impact of drivers and challenges
  • Exhibit 47: Key factors that will have a positive impact on the market growth
  • Exhibit 48: Emergence of hybrid approach in LAA closure
  • Exhibit 49: Ongoing clinical trials of LAA closure device
  • Exhibit 50: M&A
  • Exhibit 51: Market share analysis of vendors in LAA closure market 2016
  • Exhibit 52: Competitive structure analysis of global LAA closure market 2016
  • Exhibit 53: Market penetration of various manufacturers of global LAA closure market 2016
  • Exhibit 54: Strategic success factors of companies in global LAA closure market
  • Exhibit 55: Key highlights of AtriCure
  • Exhibit 56: AtriCure strength assessment
  • Exhibit 57: AtriCure strategy assessment
  • Exhibit 58: AtriCure: Opportunity assessment
  • Exhibit 59: Key highlights of Boston Scientific
  • Exhibit 60: Boston Scientific: Strength assessment
  • Exhibit 61: Boston Scientific: Strategy assessment
  • Exhibit 62: Boston Scientific: Opportunity assessment
  • Exhibit 63: Key highlights of Coherex Medical
  • Exhibit 64: Coherex Medical: Strength assessment
  • Exhibit 65: Coherex Medical: Strategy assessment
  • Exhibit 66: Coherex Medical: Opportunity assessment
  • Exhibit 67: Key highlights of St. Jude Medical
  • Exhibit 68: St. Jude Medical: Strength assessment
  • Exhibit 69: St. Jude Medical: Strategy assessment
  • Exhibit 70: St. Jude Medical: Opportunity assessment
Back to Top